国家神经系统疾病临床医学研究中心数据管理与共享系统

Data Management And Sharing System of China National Clinical Research Center for Neurological Diseases

IDH mutation-specific radiomic signature in lower-grade gliomas

第一作者:Liu Xing,Li Yiming

通讯作者:Wang Yinyan

isocitrate dehydrogenase lower grade gliomas progn

基本信息

2019-01-29

已发表文章

发表杂志:Aging

发表类型: Research Paper

影响因子(IF): 5.515

PMID: 30696801 Pubmed原文链接 全文下载

主要研究背景及目的

方法

In this study, we extracted quantitative image features from T2-weighted MR images and revealed that the isocitrate dehydrogenase (IDH) wild type and mutant lower grade gliomas (LGGs) differed in their expression of 146 radiomic descriptors.

结论

This radiomic signature may provide a way to non-invasively discriminate lower-grade gliomas as with or without the IDH mutation.

主要结果

The logistic regression model algorithm further reduced these to 86 features. The classification model could discriminate the two types in both the training and validation sets with area under the curve values of 1.0000 and 0.9932, respectively. The transcriptome-radiomic analysis revealed that these features were associated with the immune response, biological adhesion, and several malignant behaviors, all of which are consistent with biological processes that are differentially expressed in IDH wild type and IDH mutant LGGs. Finally, a prognostic signature showed an ability to stratify IDH mutant LGGs into high and low risk groups with distinctive outcomes. By extracting a large number of radiomic features, we identified an IDH mutation-specific radiomic signature with prognostic implications.